Pharmacy Law Practice Exam

Which of the following best describes non-sterile compounding?

1. Creating products that have a high-risk of causing infection

2. Developing medication standards with minimal risk of infections

3. Involving procedures requiring extensive sterilization

4. Handling pharmaceuticals used only for injectable administration

The correct answer is: Developing medication standards with minimal risk of infections

Non-sterile compounding refers to the preparation of medications that do not need to be sterile, such as creams, ointments, tablets, or capsules, which can be created with minimal risk of causing infections. This description highlights that while these products are still compounded with care and accuracy, they do not require the extreme precautions that are necessary for sterile compounding, which is essential for injectables and other routes where infection risk is much higher. The correct choice emphasizes the standards with which these medications are developed, focusing on the importance of quality and safety while acknowledging the lower infection risk associated with non-sterile compounds. In contrast, the other options describe aspects associated with sterile compounding or procedures that involve a higher risk of infection or require sterilization, which do not align with the characteristics of non-sterile compounding.